(Total Views: 403)
Posted On: 05/03/2021 9:15:22 AM
Post# of 145254
Data from 10 Patients with Stage Four Cancer Treated with Leronlimab for Nearly One Year Will Serve as Basis for Pre-Breakthrough Therapy Designation Meeting with FDA
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)